Australia markets closed

Brii Biosciences Limited (2137.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.060-0.010 (-0.93%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
617
617
51,626
0
0
-
Operating expenses
Research development
402,705
402,705
440,634
494,615
875,795
-
Selling general and administrative
57,104
57,104
80,326
47,170
34,927
-
Total operating expenses
545,349
545,349
565,814
642,614
911,884
-
Operating income or loss
-544,732
-544,732
-514,188
-642,614
-911,884
-
Interest expense
494
494
851
1,175
1,668
-
Income before tax
-184,370
-184,370
-489,781
-4,191,084
-1,283,510
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-184,370
-184,370
-489,781
-4,191,084
-1,283,510
-
Net income
-174,829
-174,829
-484,312
-4,163,849
-1,189,600
-
Net income available to common shareholders
-174,829
-174,829
-484,312
-4,163,849
-1,189,600
-
Basic EPS
-0.45
-
-0.67
-9.48
-1.68
-0.74
Diluted EPS
-0.45
-
-0.67
-9.48
-1.68
-0.74
Basic average shares
726,332
-
723,478
439,047
706,201
706,201
Diluted average shares
726,332
-
723,478
439,047
706,201
706,201